Me. Suarezalmazor et al., EUTHANASIA AND PHYSICIAN-ASSISTED SUICIDE - A COMPARATIVE SURVEY OF PHYSICIANS, TERMINALLY ILL CANCER-PATIENTS, AND THE GENERAL-POPULATION, Journal of clinical oncology, 15(2), 1997, pp. 418-427
Purpose and Methods: There is an ongoing debate about the legalization
of euthanasia. The attitudes and beliefs of the general public and ph
ysicians appear to differ; the views of patients have not been adequat
ely explored. During 1995, we conducted a simultaneous survey in the p
rovince of Alberta, Canada, of a random sample of 1,240 individuals fr
om the general population, 179 physicians, and 62 consecutive patients
with terminal cancer. The same instrument was administered to the pub
lic and physicians through telephone interview, and to patients in a f
ace-to-face interview. Statements related to the legalization of eutha
nasia: and physician-assisted suicide were scored using 1-to-7 Likert
agreement scales. Results: A slight majority of members of the public
and terminally ill patients (50% to 60%) agreed with the legalization
of euthanasia and assisted suicide, while most physicians (60% to 80%)
opposed it. In multivariate analysis, independent associations with s
upport of active end of life measures included the following: group su
rveyed, strength of religious beliefs, religion (highest support by in
dividuals with no religion), education (lower education associated wit
h higher support), and the perception of burden on families, and physi
cal and emotional suffering by cancer patients. Conclusion: In all gro
ups, a marked polarization of attitudes was observed, with most indivi
duals either strongly agreeing or strongly disagreeing with the statem
ents in the survey. Although a slight majority of the public supported
euthanasia, one third opposed it. Most physicians opposed these inter
ventions and appeared not to be willing to perform these procedures if
legalized. Our findings suggest that legalization at this time could
be highly divisive and controversial from a societal perspective, (C)
1997 by American Society of Clinical Oncology.